Niacinamide Market by Form (Granular, Liquid, Powder), Production (Natural, Synthetic), Grade, Application - Global Forecast 2024-2030
The Niacinamide Market size was estimated at USD 715.77 million in 2023 and expected to reach USD 745.60 million in 2024, at a CAGR 4.65% to reach USD 984.11 million by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Niacinamide Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Niacinamide Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Niacinamide Market, highlighting leading vendors and their innovative profiles. These include AIE Pharmaceuticals, Inc., Bio-Tech Pharmacal, Inc., Evonik Industries AG, Fagron Inc., Foodchem International Corporation, Gemini Pharmaceuticals, Glanbia PLC, Koninklijke DSM N.V., Lasons India Pvt Ltd., Lonza Group AG, Merck KGaA, NutraScience Labs, Spectrum Chemical Mfg. Corporation, Vertellus LLC, Western Drugs Ltd., and Yuki Gosei Kogyo Co., Ltd..
Market Segmentation & Coverage
This research report categorizes the Niacinamide Market to forecast the revenues and analyze trends in each of the following sub-markets:
Form
Granular
Liquid
Powder
Production
Natural
Synthetic
Grade
Feed Grade
Pharmaceutical Grade
Application
Animal Nutrition
Cosmeceuticals
Human Nutrition
Pharmaceuticals
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom
The report offers valuable insights on the following aspects:
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
1. What is the market size and forecast of the Niacinamide Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Niacinamide Market?
3. What are the technology trends and regulatory frameworks in the Niacinamide Market?
4. What is the market share of the leading vendors in the Niacinamide Market?
5. Which modes and strategic moves are suitable for entering the Niacinamide Market?
Note: PDF & Excel + Online Access - 1 Year
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Niacinamide Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Consumer demand for niacinamide-containing foods or supplements for diabetes, osteoarthritis, and hyperphosphatemia
- 5.1.1.2. Increasing demand for skin care products containing niacinamide
- 5.1.1.3. Growing use of niacinamide for animal feed fortification
- 5.1.2. Restraints
- 5.1.2.1. Limited availability and volatility of the prices of ingredients
- 5.1.3. Opportunities
- 5.1.3.1. Extensive R&D activities to develop niacinamide therapies for the treatment of cancer
- 5.1.3.2. Growing preference for Over-the-counter (OTC) cosmeceuticals
- 5.1.4. Challenges
- 5.1.4.1. Adverse side effects and allergic reactions associated with the long-term use of niacinamide
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Niacinamide Market, by Form
- 6.1. Introduction
- 6.2. Granular
- 6.3. Liquid
- 6.4. Powder
- 7. Niacinamide Market, by Production
- 7.1. Introduction
- 7.2. Natural
- 7.3. Synthetic
- 8. Niacinamide Market, by Grade
- 8.1. Introduction
- 8.2. Feed Grade
- 8.3. Pharmaceutical Grade
- 9. Niacinamide Market, by Application
- 9.1. Introduction
- 9.2. Animal Nutrition
- 9.3. Cosmeceuticals
- 9.4. Human Nutrition
- 9.5. Pharmaceuticals
- 10. Americas Niacinamide Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Niacinamide Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa Niacinamide Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. AIE Pharmaceuticals, Inc.
- 14.1.2. Bio-Tech Pharmacal, Inc.
- 14.1.3. Evonik Industries AG
- 14.1.4. Fagron Inc.
- 14.1.5. Foodchem International Corporation
- 14.1.6. Gemini Pharmaceuticals
- 14.1.7. Glanbia PLC
- 14.1.8. Koninklijke DSM N.V.
- 14.1.9. Lasons India Pvt Ltd.
- 14.1.10. Lonza Group AG
- 14.1.11. Merck KGaA
- 14.1.12. NutraScience Labs
- 14.1.13. Spectrum Chemical Mfg. Corporation
- 14.1.14. Vertellus LLC
- 14.1.15. Western Drugs Ltd.
- 14.1.16. Yuki Gosei Kogyo Co., Ltd.
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
- FIGURE 1. NIACINAMIDE MARKET RESEARCH PROCESS
- FIGURE 2. NIACINAMIDE MARKET SIZE, 2023 VS 2030
- FIGURE 3. NIACINAMIDE MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. NIACINAMIDE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. NIACINAMIDE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. NIACINAMIDE MARKET DYNAMICS
- FIGURE 7. NIACINAMIDE MARKET SIZE, BY FORM, 2023 VS 2030 (%)
- FIGURE 8. NIACINAMIDE MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2023 VS 2030 (%)
- FIGURE 10. NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. NIACINAMIDE MARKET SIZE, BY GRADE, 2023 VS 2030 (%)
- FIGURE 12. NIACINAMIDE MARKET SIZE, BY GRADE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. NIACINAMIDE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 14. NIACINAMIDE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. AMERICAS NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. AMERICAS NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. UNITED STATES NIACINAMIDE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 18. UNITED STATES NIACINAMIDE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. NIACINAMIDE MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 24. NIACINAMIDE MARKET SHARE, BY KEY PLAYER, 2023
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook